| UCB S.A. |
| Belgien |
| Gesundheit |
| BE0003739530 / 852738 |
| UNC (Frankfurt) |
| FRA:UNC, ETR:UNC, UNC:GR |
| - |
| https://www.ucb.com/ |
|
UCB SA is a multinational biopharmaceutical company headquartered in Brussels, Belgium, founded in 1928 by Emmanuel Janssen. It specializes in developing innovative medicines for severe neurological and immunological diseases, including epilepsy, Par..
>Volltext.. |
| 43967.23 Mio. EUR |
| 43742.02 Mio. EUR |
| 7757.25 Mio. EUR |
| 2641.53 Mio. EUR |
| 1561.27 Mio. EUR |
| 8.21 EUR |
| 2249.71 Mio. EUR |
| 2255.72 Mio. EUR |
| 2167.54 Mio. EUR |
| 0.56 |
| 25.83% |
| 46.29% |
| - |
| 0.42% |
| 0.45% |
| 25.04.25 - 1.39€ 26.04.24 - 1.36€ >weitere anzeigen... |
| - |
| UCB |
| 03.05.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|